Steris | STE - Interest Expense On Debt


Steris reported $11.2M in Interest Expense on Debt for its fiscal quarter ending in September of 2026.





Interest Expense On Debt Change Date
3M USD 217M 15M Sep/2026
Accuray USD 2.88M 72K Dec/2024
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Boston Scientific USD 100M 4M Sep/2026
CONMED USD 11.14M 3.25M Sep/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 100K Sep/2026
Ecolab USD 135.8M 69.3M Sep/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Fortive USD 38.8M 3.4M Sep/2026
Getinge SEK 133M 31M Jun/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Haemonetics USD 5.08M 2.32M Mar/2026
Idexx Laboratories USD 7.46M 2.72M Sep/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 12.3M 1.3M Sep/2026
Integra LifeSciences USD 22.96M 33K Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 43M 25M Mar/2026
Olympus JPY 2.41B 408M Sep/2026
Orthofix International 4.68M 731K Sep/2025
Owens Minor USD 27.93M 1.1M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Steris USD 11.2M 4.6M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 21.21M 6.75M Sep/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026